Pelthos Therapeutics, Inc. (PTHS)
22.85
+0.20
(+0.88%)
USD |
NYAM |
Sep 21, 16:00
22.85
0.00 (0.00%)
After-Hours: 20:00
Pelthos Therapeutics Market Cap : 84.97M for Sept. 21, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 18, 2026 | 84.23M |
| September 17, 2026 | 83.22M |
| September 16, 2026 | 72.22M |
| September 15, 2026 | 75.56M |
| September 14, 2026 | 81.59M |
| September 11, 2026 | 81.44M |
| September 10, 2026 | 83.41M |
| September 09, 2026 | 87.09M |
| September 08, 2026 | 91.29M |
| September 04, 2026 | 90.55M |
| September 03, 2026 | 90.59M |
| September 02, 2026 | 93.08M |
| September 01, 2026 | 92.30M |
| August 31, 2026 | 89.54M |
| August 28, 2026 | 91.96M |
| August 27, 2026 | 92.96M |
| August 26, 2026 | 99.58M |
| August 25, 2026 | 101.15M |
| August 24, 2026 | 98.99M |
| August 21, 2026 | 94.86M |
| August 20, 2026 | 99.14M |
| August 19, 2026 | 96.01M |
| August 18, 2026 | 97.09M |
| August 17, 2026 | 96.31M |
| August 14, 2026 | 102.26M |
| Date | Value |
|---|---|
| August 13, 2026 | 107.65M |
| August 12, 2026 | 107.50M |
| August 11, 2026 | 106.46M |
| August 10, 2026 | 107.84M |
| August 07, 2026 | 95.57M |
| August 06, 2026 | 99.24M |
| August 05, 2026 | 96.18M |
| August 04, 2026 | 89.98M |
| August 03, 2026 | 90.45M |
| July 31, 2026 | 96.58M |
| July 30, 2026 | 88.46M |
| July 29, 2026 | 86.74M |
| July 28, 2026 | 93.58M |
| July 27, 2026 | 92.98M |
| July 24, 2026 | 87.35M |
| July 23, 2026 | 95.71M |
| July 22, 2026 | 89.20M |
| July 21, 2026 | 90.52M |
| July 20, 2026 | 91.86M |
| July 17, 2026 | 90.95M |
| July 16, 2026 | 90.01M |
| July 15, 2026 | 91.66M |
| July 14, 2026 | 85.60M |
| July 13, 2026 | 88.46M |
| July 10, 2026 | 89.47M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Travere Therapeutics, Inc. | 5.917B |
| ACADIA Pharmaceuticals, Inc. | 4.543B |
| Alnylam Pharmaceuticals, Inc. | 32.66B |
| Anika Therapeutics, Inc. | 277.30M |
| Savara, Inc. | 1.120B |
Market Cap Related Metrics
| PS Ratio | 1.724 |
| PEG Ratio | -0.0046 |
| Price | 22.85 |
| Earnings Yield | -115.4% |
| PEGY Ratio | -0.0046 |